The Impact of Serum Vancomycin Levels and Minimum Inhibitory Concentrations of Methicillin-Resistant Staphylococcus aureus on Mortality in Patients with Nosocomial Pneumonia

The Impact of Serum Vancomycin Levels and Minimum Inhibitory Concentrations of Methicillin-Resistant Staphylococcus aureus on Mortality in Patients with Nosocomial Pneumonia

BACKGROUND: Vancomycin is the treatment of choice for methicillin-resistant Staphylococcus aureus (MRSA) infections; however, treatment failure is not uncommon, even when the minimum inhibitory concentration (MIC) of the MRSA strain is within the susceptible range for vancomycin.

Saved in:
Bibliographic Details
Main Authors: Denise Pires Machado, Luciano Z Goldani, Rodrigo Minuto Paiva, Valério Rodrigues Aquino, Fernanda de-Paris, Thiago Lisboa, Bruno Jung, Rodrigo Pires dos Santos
Format: Article
Language:English
Published: Wiley 2013-01-01
Series:Canadian Journal of Infectious Diseases and Medical Microbiology
Online Access:http://dx.doi.org/10.1155/2013/585834
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items